Tuesday, June 6, 2017

=Aldeyra Therapeutics (ALDX)


  • Aldeyra (ALDX) has enrolled the first patient into a Phase 2a clinical trial of topical ocular ADX-102 for the treatment of Dry Eye Disease.

Posted by at
Labels: , ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)